Mird237 2021 __full__ 💯 Instant
If you are a medical physicist, a nuclear medicine resident, a radiopharmacist, or a health physicist, understanding is non-negotiable for modern targeted radionuclide therapy (TRT), including treatments like Lu-177 DOTATATE, I-131, and Y-90 microspheres.
Studies published in late 2021, often in the Journal of Nuclear Medicine (Supplement 3), analyzed the role of molecular imaging (PET/SPECT) in guiding therapeutic decisions based on imaging phenotypes, molecular imaging-derived tumoral heterogeneity, and dosimetry. mird237 2021
